Interestingly, CD5 expression had been central in correctly identifying all ETP-ALL cases: to recognize ETP-ALL, the authors did not include CD5 but relied on CD7+, with CD34+ and/or CD13+/CD33+, whereas CD1, CD4, CD8 were negative [28]. Here, CD8A is linked to acute lymphoblastic leukemia.